Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Avricore Health Inc V.AVCR

Alternate Symbol(s):  AVCRF

Avricore Health Inc. is a pharmacy service innovator focused on acquiring and developing early-stage technologies aimed at advancing pharmacy practice and patient care. The Company is involved in the business of health data and point-of-care technologies (POCT). HealthTab, its flagship offering, is a turnkey point-of-care testing solution that combines point-of-care technologies with a secure, cloud-based platform for tackling pressing global health issues. With just a few drops of blood from a finger prick, the system generates lab-accurate results on the spot and data is reported in real time. The test menu includes up to 23 key biomarkers for screening and managing chronic diseases, such as diabetes and heart disease (e.g., HbA1c, Lipid Profile, eGFR). The HealthTab also has capabilities for bacterial and viral tests, such as strep and COVID-19. The HealthTab platform transforms pharmacies into community point-of-care diagnostic centers.


TSXV:AVCR - Post by User

Bullboard Posts
Post by kingposton Mar 29, 2016 12:11pm
301 Views
Post# 24707741

More OTC coming...more Generics coming...Brand drugs coming.

More OTC coming...more Generics coming...Brand drugs coming.Arun from  NPH iron suppliment PR:..."We plan to add additional OTC product to our portfolio in the near future.".........This comment is at the end of his quote and is the most important part IMO.....would he say this if nothing is in the works behind the scenes?
The OTC and generics divisions are synergistic and feed off of each other in leveraging the NPH business model...  I think Arun understated and could have said "many additional"... understate and overdeliver is good though..

In addition to OTC and Generics, I am predicting it is only a matter of time until  NPH starts to land some brand drug rights for Canada since the strong manufacturing and distribution connections will be leveraged to make NPH  a top partner candidate...N and so the third prong of the business model, (Brand drugs that fit the pharmacy model) will start to do some heavy lifting on the income statement, and also be synergistic to the other two divisions creating , IMO, a very strong  and unique (compared to competitors), and highly synergistic tri-pronged, ,  business model......OTC, Generics and Brand...


Bullboard Posts